By Defending Potti, Duke Officials Become Target Of Charges Of Institutional Failure
Duke Officials Decline To Provide Details Of Probe
Biostatisticians Write To Varmus Asking NCI To Investigate
The Lancet Oncology Issues “Expression Of Concern” Over Paper
Duke Insiders Allege Intimidation By Administration
Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Did peer review fail? Nature Medicine’s chronotherapy paper retraction raises questions
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- The future of oncology: Early-career scientists need mentorship and a new academic model
- The Directors: Two leaders in data science have a warp speed vision for AI, with cancer clinical trials leading the way
Knudsen and Thoelke: “It’s actually solving for bottlenecks and challenges that we’ve been unable to overcome for so long” - A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m.









